RoslinCT Announces the Appointment of Dr. Derek Hei to its Scientific Advisory Board

EDINBURGH, Scotland & BOSTON–(BUSINESS WIRE)– #CDMO–RoslinCT, a leading contract development and manufacturing organization (CDMO) for Advanced Cell and Gene therapies, announced the appointment of Derek Hei, Ph.D., to its Scientific Advisory Board (SAB). The SAB is comprised of cell and gene therapy pioneers with extensive experience, providing valuable insight into a range of topics for the development and manufacturing of advanced therapies. Dr. Hei is Chief Technology Officer (CTO) at Clade Ther

Recent Articles